TLK2 and cancer: Their anti-cancer mechanisms involve the promotion of oncoprotein [e.g., c-MYC, E2F (E2 promoter binding factor) and TLK2 (tousled like kinase 2)] degradation, cell cycle arrest, apoptosis, cytotoxic immunity and metabolic defects 19.